What is Rani Therapeutics Holdings 12-1 Month Momentum %?
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2025-04-22), Rani Therapeutics Holdings's 12-1 Month Momentum % is -78.08%.
The industry rank for Rani Therapeutics Holdings's 12-1 Month Momentum % or its related term are showing as below:
RANI's 12-1 Month Momentum % is ranked worse than 88.54% of 1440
companies
in the Biotechnology industry
Industry Median: -18.37
vs RANI: -78.08
Competitive Comparison of Rani Therapeutics Holdings's 12-1 Month Momentum %
For the Biotechnology subindustry, Rani Therapeutics Holdings's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rani Therapeutics Holdings's 12-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Rani Therapeutics Holdings's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Rani Therapeutics Holdings's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Rani Therapeutics Holdings 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Rani Therapeutics Holdings's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RANI has been successfully added to your